The Geostationary Ocean Color Imager (GOCI) is the first optical sensor in geostationary orbit for monitoring the ocean environment around the Korean Peninsula. This paper discusses on-orbit modulation transfer function (MTF) estimation with the pulse-source method and its compensation results for the GOCI. Additionally, by analyzing the relationship between the MTF compensation effect and the accuracy of the secondary ocean product, we confirmed the optimal MTF compensation parameter for enhancing image quality without variation in the accuracy. In this study, MTF assessment was performed using a natural target because the GOCI system has a spatial resolution of 500 m. For MTF compensation with the Wiener filter, we fitted a point spread function with a Gaussian curve controlled by a standard deviation value (σ). After a parametric analysis for finding the optimal degradation model, the σ value of 0.4 was determined to be an optimal indicator. Finally, the MTF value was enhanced from 0.1645 to 0.2152 without degradation of the accuracy of the ocean color product. Enhanced GOCI images by MTF compensation are expected to recognize small-scale ocean products in coastal areas with sharpened geometric performance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1364/OE.22.026908 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Best Practices for Measuring the Modulation Transfer Function of Video Endoscopes.
Sensors (Basel)
August 2024
Department of Electrical Engineering and Computer Science, The Catholic University of America, Washington, DC 20064, USA.
Endoscopes are crucial for assisting in surgery and disease diagnosis, including the early detection of cancer. The effective use of endoscopes relies on their optical performance, which can be characterized with a series of metrics such as resolution, vital for revealing anatomical details. The modulation transfer function (MTF) is a key metric for evaluating endoscope resolution.
View Article and Find Full Text PDFRedefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
J Neurol Neurosurg Psychiatry
September 2024
Headache Clinic, Neurology Department, Vall d'Hebron Hospital, Barcelona, Spain
Article Synopsis
- Anti-CGRP monoclonal antibodies are effective treatments for preventing migraines, but patients show varied responses, influenced by specific clinical factors.
- A study involving over 5,800 patients identified key predictors of treatment response at 6 months, including older age, unilateral pain, absence of depression, fewer monthly migraine days, and lower disability levels.
- The findings highlight that higher migraine frequency and greater baseline disability negatively impact treatment effectiveness, which can inform future patient management and reimbursement policies.
Head-mounted adaptive optics visual simulator.
Biomed Opt Express
February 2024
Laboratorio de Óptica, Universidad de Murcia, Campus de Espinardo (Edificio 34), 30100 Murcia, Spain.
Adaptive optics visual simulation is a powerful tool for vision testing and evaluation. However, the existing instruments either have fixed tabletop configurations or, being wearable, only offer the correction of defocus. This paper proposes a novel head-mounted adaptive optics visual simulator that can measure and modify complex ocular aberrations in real-time.
View Article and Find Full Text PDFEarly and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population.
J Headache Pain
February 2024
Headache Clinic, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Background: Migraine is one of the main causes of disability worldwide. Anti-CGRP monoclonal antibodies (MAbs) have proven to be safe and efficacious as preventive migraine treatments. However, their use is restricted in many countries due to their apparently high cost.
View Article and Find Full Text PDFDisparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort.
Neurology
February 2024
From the University of California San Francisco (A.M.R.); Department of Neurology (L.A.), University of Southern California, Los Angeles; Department of Neurology (A.A., S.P., R. Bove), UCSF Weill Institute for the Neurosciences, and Department of Neurology (S.G.), University of California San Francisco; Department of Neurology (S.A., E.L.G.), Northwestern University, Chicago, IL; Department of Neurology (R. Brandstadter, D.A.J., V.Z., L.Z.), Hospital of the University of Pennsylvania, Philadelphia; Corinne Goldsmith Dickinson Center for MS (M.T.F., I.B.K.S., A.K., J.P., S.S., E.V.), Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY; Brigham and Women's Hospital (S.H., M.K.H.), Boston, MA; University of Texas Southwestern Medical Center (L.H., L.T.), Dallas; Center for Translational and Computational Neuroimmunology and Multiple Sclerosis Center (L.L., C.R.), Department of Neurology, Columbia University Irving Medical Center, New York, NY; Family Health Care Nursing Department (M.M.), School of Nursing, University of California San Francisco; North Texas Institute of Neurology and Headache (A.F.O.), Frisco; University of Southern California (V.V.), Los Angeles; and Joi Life Wellness Group (M.J.W.), Multiple Sclerosis Center, Smyrna, GA.
Background And Objectives: Racial disparities exist in both neurologic and obstetric populations, underscoring the importance of evaluating pregnancy outcomes in diverse women with multiple sclerosis (MS). The objective of this multicenter retrospective study was to compare pregnancy care and outcomes between Black and Hispanic (underrepresented) and White women with MS.
Methods: Demographic and clinical data were extracted from medical records of 9 US MS centers for women with MS/clinically isolated syndrome who delivered live births between 2010 and 2021.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!